Video Latest - ecancer

FAP-targeted molecular radiotherapy in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA

1 Apr 2022

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA

8 Mar 2022

Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective

Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina

3 Mar 2022

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA

3 Mar 2022

Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer

Dr Meghana Pagadala - University of California San Diego, San Diego, USA

25 Feb 2022

Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL

Dr Juliana Pereira & Dr Steven Horwitz

22 Feb 2022

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

17 Feb 2022

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal

3 Feb 2022

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz

1 Feb 2022

OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO

Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Franco & Dr Kathleen Schemeler

19 Jan 2022

OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more

Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla Karim, Dr Fumiko Chino, Dr Narjust Duma & Dr Nicole Kuderer

19 Jan 2022

OncoAlert Colloquium Day 4: GI oncology and EONS

Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewis, Dr Nina Niu Sanford, Mr Johan de Munter & Dr Merel Van Klinken

19 Jan 2022

Video